The MCP-3/Ccr3 axis contributes to increased bone mass by affecting osteoblast and osteoclast differentiation

참고문헌 (27)

1. Kim, J. H., "Bone cell communication factors provide a new therapeutic strategy for osteoporosis", Chonnam Med J, 56, pp.94~98 (2020)
2. Lee, H. Y., "Iris Koreana NAKAI inhibits osteoclast formation via p38-mediated nuclear factor of activated T cells 1 signaling pathway", J. Bone Metab, 30, pp.253~262 (2023)
3. Kim, K., "LIM homeobox transcription factor 1-βexpression is upregulated in patients with osteolysis after total ankle arthroplasty and inhibits receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation in vitro", J. Bone Metab, 29, pp.165~174 (2022)
4. Wintges, K., "Impaired bone formation and increased osteoclastogenesis in mice lacking chemokine(C-C motif)ligand 5(Ccl5)", J. Bone Min. Res, 28, pp.2070~2080 (2013)
5. Sabatini, M., "Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice", Proc. Natl. Acad. Sci. USA, 85, pp.5235~5239 (1988)
6. Jimi, E., "Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts", stromal cells, 1999, pp.247, 84~93
7. Yamada, N., "Interleukin-18 and interleukin-12 synergistically inhibit osteo clastic bone-resorbing activity", Bone, 30, pp.901~908 (2002)
8. Schulze, J., "Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells", J. Bone Min. Res, 26, pp.704~717 (2011)
9. Ishimi, Y., "IL-6 is produced by osteoblasts and induces bone resorption", J. Immunol, 145, pp.3297~3303 (1990)
10. De Benedetti, F., "Impaired skeletal development in interleukin-6-transgenic mice : a model for the impact of chronic inflammation on the growing skeletal system", Arthritis Rheum, 54, pp.3551~3563 (2006)
11. Bertolini, D. R., "Sti mulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors", Nature, 319, pp.516~518 (1986)
12. Kitase, Y., "CCL7 is a protective factor secreted by mechanically loaded osteocytes", J. Dent. Res, 93, pp.1108~1115 (2014)
13. Van Damme, J., "Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP 2 and MCP-3) belonging to the chemokine family", J. Exp. Med, 176, pp.59~65 (1992)
14. Liu, Y., "Crucial biological functions of CCL7 in cancer", PeerJ, 6, pp.e4928~ (2018)
15. Ford, J., "CCL7 is a negative regulator of cutaneous inflammation following leishmania major infection", Front Immunol, 9, pp.3063~ (2018)
16. Ben-Baruch, A., "Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors. C-C CKR1, a receptor for macrophage inflammatory protein-1 alpha", Rantes, is also a functional receptor for MCP3, 1995, pp.270, 22123~22128
17. Hu, J. Y., "Transfection of colorectal cancer cells with chemokine MCP-3(monocyte chemotactic protein-3)gene retards tumor growth and inhibits tumor metastasis", World J. Gastroenterol, 8, pp.1067~1072 (2002)
18. Liu, S. Q., "Induction of human autologous cytotoxic T lymphocytes on formalin-fixed and paraffin-embedded tumour sections", Nat. Med, 1, pp.267~271 (1995)
19. Yu, X., "CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts", J. Bone Min. Res, 19, pp.2065~2077 (2004)
20. Rosendahl, S., "CCR3 deficiency is associated with increased osteoclast activity and reduced cortical bone volume in adult male mice", J. Biol. Chem, 296, pp.100177~ (2021)
21. Brylka, L. J., "Chemokines in physiological and pathological bone remodeling", Front Immunol, 10, pp.2182~ (2019)
22. Hu, X., "Irisin as an agent for protecting against osteoporosis : a review of the current mechanisms and pathways", J. Adv. Res, 62, pp.175~186 (2024)
23. Lee, J., "Irisin promotes C2C12 myoblast proliferation via ERK-dependent CCL7 upregulation", PLoS One, 14, pp.e0222559~ (2019)
24. Nöth, U., "Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts", Exp. Cell Res, 291, pp.201~211 (2003)
25. Park, J. H., "Current understanding of RANK signaling in osteoclast differentiation and maturation", Mol. Cells, 40, pp.706~713 (2017)
26. Takayanagi, H., "RANKL maintains bone homeostasis through c-Fos dependent induction of interferon-beta", Nature, 416, pp.744~749 (2002)
27. Zhang, J., "Exercise-induced irisin in bone and systemic irisin administration reveal new regulatory mechanisms of bone metabolism", Bone Res, 5, pp.16056~ (2017)

관련 논문AI추천